On January 23,2026, the launch event for the "Converging Jing-Shen Momentum, Co-creating a Healthy Future" Shenyang International Life Health City Construction Plan and the Shenyang-Zhongguancun Jing-Shen Collaborative Innovation Cooperation Exchange was successfully held at the Shenyang Zhongguancun Intelligent Manufacturing Innovation Center. The event focused on the high-quality development of the life health industry, presenting the comprehensive construction plan for the Shenyang International Life Health City and showcasing the latest achievements and collaborative opportunities in the field of biomedicine and life health through Jing-Shen collaborative innovation.

Under the joint witness of Shenyang municipal leaders, representatives from Shenyang Economic and Technological Development Zone, and relevant officials from Tiexi District, Wang Lei, Business Director of Cell Valley Group for Northeast China, signed a strategic cooperation agreement with Shenyang Economic and Technological Development Zone on behalf of the group. The two parties will engage in in-depth collaboration focusing on cell and gene therapy, development of life health industry platforms, technology commercialization, and cultivation of industrial ecosystems, jointly promoting the clustering and development of high-end biopharmaceutical industries in Shenyang.

The signing ceremony for the project entry was photographed by the Publicity Department of Tiexi District Committee.

In the release and exchange session, Wang Lei, on behalf of Cell Valley Group, first expressed sincere gratitude to the leaders of Shenyang City and the Economic Development Zone for their enthusiastic investment promotion. He then gave a systematic introduction to the Group’s development layout, core technology platforms, and practical experience in the industrialization of cell and gene therapy.Wang Lei stated that Cell Valley Group has decided to establish a presence in Shenyang, basing itself in Shenyang, serving Northeast China, and radiating to Northeast Asia. The Group has officially started preparations for the construction of Shenyang Cell Valley and has selected a site in Shenyang International Life and Health City. Shenyang Cell Valley will be positioned as a municipal one-stop service platform for cell and gene therapy, focusing on building a one-stop clinical translation platform that enables the most effective implementation of IIT projects.

According to reports, Shenyang Cell Valley will rely on the institutional framework established under national policies such as 《the Regulations on the Administration of Clinical Research and Translational Application of New Biomedical Technologies (for Trial Implementation)》 (commonly known in the industry as “Document No. 818”).

It will assist Class III Grade A hospitals in the Liaoshen region to systematically complete key procedures including project compliance filing, review and approval in accordance with the requirements of national and provincial authorities. This will support the steady transformation of innovative projects from IIT research to standardized clinical application, and their inclusion in the fee-charging management system in accordance with laws and regulations, effectively opening up the key chain of “research – clinical practice – compliance – application”.

This event was characterized by high prestige and broad influence, with attendance from multiple municipal leaders of Shenyang. The participating officials included Guo Zhongxiao, Member of the Standing Committee of the Shenyang Municipal Party Committee, Secretary of the Political and Legal Affairs Commission, and Secretary of the Tiexi District Party Committee, as well as Zhao Wei, Vice Mayor of Shenyang. Representatives from relevant municipal departments, district and county authorities, as well as delegates from research institutions, innovation platforms, and enterprises jointly attended the event.

All participants unanimously agreed that the construction of Shenyang International Life and Health City serves as a pivotal initiative to promote collaborative innovation between Beijing and Shenyang and accelerate the comprehensive revitalization of Northeast China. The signing of the strategic cooperation agreement between Cell Valley Group and Shenyang Economic and Technological Development Zone marks a critical step in the deep integration of the high-end cell and gene therapy industry with the development of Shenyang's life and health industry. This collaboration will inject new and robust momentum into regional industrial upgrading, technological innovation, and high-quality development.